Literature DB >> 35272283

The Care of Transgender Young People.

Damian Krebs, Rebecca M Harris, Alyssa Steinbaum, Sarah Pilcher, Carly Guss, Jessica Kremen, Stephanie A Roberts, Charumathi Baskaran, Jeremi Carswell, Kate Millington.   

Abstract

Clinicians of all disciplines, including pediatric endocrinologists, are likely to encounter transgender and gender diverse (TGD) young people in their practice regardless of whether they specialize in gender-affirming medical care. Because of this, it is important to be aware of the ways in which medical professionals can affirm these individuals. Although gender-affirming therapy should always include affirmation including proper use of names and pronouns, the transition journey will look different for each patient. The gender-affirming care of TGD young people may include both medical and non-medical interventions (e.g., social transition). Therapies utilized for medical gender-transition such as gonadotropin-releasing hormone agonists and/or gender-affirming hormones have implications for growth, bone health, cardiovascular health, and fertility, although these impacts are not yet completely understood. This review provides an overview of the care of transgender young people as well as a summary of what is known about the outcomes of these therapies. Clinicians should advise TGD young people and their families of the known and unknown risks and work together with patients to decide upon a treatment and follow-up regimen that aligns with their individual gender affirmation and health goals. S. Karger AG, Basel.

Entities:  

Year:  2022        PMID: 35272283      PMCID: PMC9463393          DOI: 10.1159/000524030

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   4.275


  64 in total

1.  Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.

Authors:  S Bertelloni; G I Baroncelli; M Ferdeghini; F Menchini-Fabris; G Saggese
Journal:  Eur J Pediatr       Date:  2000-05       Impact factor: 3.183

2.  Mental Health of Transgender Children Who Are Supported in Their Identities.

Authors:  Kristina R Olson; Lily Durwood; Madeleine DeMeules; Katie A McLaughlin
Journal:  Pediatrics       Date:  2016-02-26       Impact factor: 7.124

3.  Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.

Authors:  Mariska C Vlot; Daniel T Klink; Martin den Heijer; Marinus A Blankenstein; Joost Rotteveel; Annemieke C Heijboer
Journal:  Bone       Date:  2016-11-11       Impact factor: 4.398

4.  Bone Health in the Transgender Population.

Authors:  Micol S Rothman; Sean J Iwamoto
Journal:  Clin Rev Bone Miner Metab       Date:  2019-07-02

5.  Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents.

Authors:  Anna Neyman; John S Fuqua; Erica A Eugster
Journal:  J Adolesc Health       Date:  2019-01-04       Impact factor: 5.012

6.  Oxandrolone Use in Trans-Masculine Youth Appears to Increase Adult Height: Preliminary Evidence.

Authors:  Frances W Grimstad; Michelle M Knoll; Jill D Jacobson
Journal:  LGBT Health       Date:  2021-04-05       Impact factor: 4.151

7.  Chosen Name Use Is Linked to Reduced Depressive Symptoms, Suicidal Ideation, and Suicidal Behavior Among Transgender Youth.

Authors:  Stephen T Russell; Amanda M Pollitt; Gu Li; Arnold H Grossman
Journal:  J Adolesc Health       Date:  2018-03-30       Impact factor: 5.012

Review 8.  Fertility concerns of the transgender patient.

Authors:  Philip J Cheng; Alexander W Pastuszak; Jeremy B Myers; Isak A Goodwin; James M Hotaling
Journal:  Transl Androl Urol       Date:  2019-06

9.  Association of High-Density Lipoprotein Cholesterol With Sex Steroid Treatment in Transgender and Gender-Diverse Youth.

Authors:  Kate Millington; Courtney Finlayson; Johanna Olson-Kennedy; Robert Garofalo; Stephen M Rosenthal; Yee-Ming Chan
Journal:  JAMA Pediatr       Date:  2021-05-01       Impact factor: 16.193

10.  Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands.

Authors:  Christel J M de Blok; Chantal M Wiepjes; Nienke M Nota; Klaartje van Engelen; Muriel A Adank; Koen M A Dreijerink; Ellis Barbé; Inge R H M Konings; Martin den Heijer
Journal:  BMJ       Date:  2019-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.